MOSAIC CO MOS

Healthcare SIC 2870 - Agricultural Chemicals NAICS Manufacturing › Chemical Manufacturing › Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing › Fertilizer and Compost Manufacturing derived NYSE

The Mosaic Company is the world's leading producer and marketer of concentrated phosphate and potash crop nutrients. Through our broad product offering, we are a single source supplier of phosphate- and potash-based crop nutrients and animal feed ingredients. We serve customers in approximately 40 countries. We are the second largest integrated phosphate producer in the world and one of the largest producers and marketers of phosphate-based animal feed ingredients in North America and Brazil. We are the leading fertilizer production and distribution company in Brazil. We mine phosphate rock in Florida, Brazil and Peru. We process rock into finished phosphate products at facilities in Florida, Louisiana and Brazil. We are typically one of the top four global potash producers in the world. We mine potash in Saskatchewan and New Mexico. We have other production, blending or distribution operations in Brazil, China, India and Paraguay. Our operations serve the top four nutrient-consuming countries in the world: China, India, U.S. and Brazil.

Last close 17.84 2026-10-23
Market cap $5.67B 2026-06-30 share count
52-week range 16.99 - 32.25

Valuation FY2025 figures against the last close

P/S0.5x
P/E10.5x
P/FCF—
EV/EBITDA3.3x
Dividend yield4.9%
Diluted EPS1.70

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $12.05B$11.12B$13.70B$19.13B$12.36B$8.68B$8.91B$9.59B$7.41B$7.16B
Cost of revenue $10.15B$9.61B$11.49B$13.37B$9.16B$7.62B$8.01B$8.09B$6.57B$6.35B
Gross profit $1.90B$1.51B$2.21B$5.76B$3.20B$1.06B$897.3M$1.50B$842.8M$810.0M
SG&A $533.9M$496.9M$500.5M$498.0M$430.5M$371.5M$354.1M$341.1M$301.3M$304.2M
Operating income $821.5M$621.5M$1.34B$4.79B$2.47B$412.9M-$1.09B$928.3M$465.7M$319.0M
Interest expense $241.5M$230.0M$189.0M$168.8M$194.3M$214.1M$216.0M$215.8M$171.3M$140.6M
Pre-tax income $1.21B$315.4M$1.33B$4.64B$2.22B$180.9M-$1.26B$551.5M$374.0M$242.4M
Income tax $639.8M$186.7M$177.0M$1.22B$597.7M$578.5M$224.7M$77.1M$494.9M$74.2M
Net income $541.0M$175.0M$1.17B$3.58B$1.63B$666.1M-$1.07B$470.0M-$107.2M$297.8M
EPS, basic 1.700.553.5210.174.311.76-2.781.22-0.310.85
EPS, diluted 1.700.553.5010.064.271.75-2.781.22-0.310.85
Shares, diluted (wtd. avg.) 318.9M320.7M333.2M356.0M381.6M381.3M383.8M386.4M350.9M351.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $276.6M$272.8M$348.8M$754.1M$786.3M$594.4M$532.3M$871.0M$2.19B$711.4M
Receivables $1.08B$1.11B$1.27B$1.70B$1.53B$881.1M$803.9M$838.5M$642.6M$627.8M
Inventory $3.36B$2.55B$2.52B$3.54B$2.74B$1.74B$2.08B$2.27B$1.55B$1.39B
Total current assets $5.24B$4.50B$4.75B$6.56B$5.33B$3.52B$3.72B$4.24B$4.62B$3.06B
Property, plant and equipment $13.98B$13.35B$13.59B$12.68B$12.48B$11.85B$11.69B$11.75B$9.71B$9.20B
Goodwill $1.01B$1.06B$1.14B$1.12B$1.17B$1.17B$1.16B$1.71B$1.69B$1.63B
Total assets $24.48B$22.92B$23.03B$23.39B$22.04B$19.79B$19.30B$20.12B$18.63B$16.84B
Accounts payable $1.17B$1.16B$1.17B$1.29B$1.26B$769.1M$680.4M$780.9M$540.9M$471.8M
Short-term debt $759.9M$847.1M$399.7M$224.9M$302.8M$100.0K$41.6M$11.5M$6.1M$100.0K
Total current liabilities $3.98B$4.17B$3.87B$5.53B$4.79B$3.15B$2.59B$2.48B$2.03B$1.48B
Retained earnings $14.18B$13.93B$14.24B$14.20B$12.01B$10.51B$9.92B$11.06B$10.63B$10.86B
Total equity $12.08B$11.48B$12.43B$12.19B$10.75B$9.76B$9.37B$10.60B$9.64B$9.62B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $824.8M$1.30B$2.41B$3.94B$2.19B$1.58B$1.10B$1.41B$935.5M$1.26B
Depreciation and amortisation $1.05B$1.03B$960.6M$933.9M$812.9M$847.6M$882.7M$883.9M$665.5M$711.2M
Stock-based compensation $30.7M$31.8M$33.0M$27.9M$29.5M$17.8M$27.9M$27.5M$28.0M$30.5M
Capital expenditure $1.36B$1.25B$1.40B$1.25B$1.29B$1.17B$1.27B$954.5M$820.1M$843.1M
Investing cash flow -$1.31B-$1.26B-$1.32B-$1.26B-$1.32B-$1.19B-$1.36B-$1.94B-$667.8M-$1.87B
Financing cash flow $452.0M-$131.9M-$1.48B-$2.68B-$682.1M-$283.8M-$82.2M-$724.8M$1.20B-$888.6M
Dividends paid $280.4M$270.7M$351.6M$197.7M$103.7M$75.8M$67.2M$38.5M$210.6M$385.1M
Buybacks $0$235.4M$756.0M$1.67B$410.9M$0$149.9M$0$0$75.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001285785-26-000061.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -10B 0 10B 20B Revenue, FY2016: 7.2B Gross profit, FY2016: 810M Net income, FY2016: 297.8M Revenue, FY2017: 7.4B Gross profit, FY2017: 842.8M Net income, FY2017: -107.2M Revenue, FY2018: 9.6B Gross profit, FY2018: 1.5B Net income, FY2018: 470M Revenue, FY2019: 8.9B Gross profit, FY2019: 897.3M Net income, FY2019: -1.1B Revenue, FY2020: 8.7B Gross profit, FY2020: 1.1B Net income, FY2020: 666.1M Revenue, FY2021: 12.4B Gross profit, FY2021: 3.2B Net income, FY2021: 1.6B Revenue, FY2022: 19.1B Gross profit, FY2022: 5.8B Net income, FY2022: 3.6B Revenue, FY2023: 13.7B Gross profit, FY2023: 2.2B Net income, FY2023: 1.2B Revenue, FY2024: 11.1B Gross profit, FY2024: 1.5B Net income, FY2024: 175M Revenue, FY2025: 12.1B Gross profit, FY2025: 1.9B Net income, FY2025: 541M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $7.16B $7.41B $9.59B $8.91B $8.68B $12.36B $19.13B $13.70B $11.12B $12.05B
Gross profit $810.0M $842.8M $1.50B $897.3M $1.06B $3.20B $5.76B $2.21B $1.51B $1.90B
Net income $297.8M -$107.2M $470.0M -$1.07B $666.1M $1.63B $3.58B $1.17B $175.0M $541.0M

Recent filings and events

  • Debt acceleration or default Something has triggered a lender's right to demand early repayment - usually a covenant breach. Item 2.04
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Other event Item 8.01
  • Other event Item 8.01
  • Other event Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Material impairment The company has written down the carrying value of an asset - often goodwill from an acquisition that did not work out. Item 2.06
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2870

TickerCompanyMarket capP/ERevenue growth
CF CF Industries Holdings, Inc. $18.26B 13.5x 19.3%
SMG SCOTTS MIRACLE-GRO CO $3.45B 24.0x -3.9%
UAN CVR PARTNERS, LP $1.33B 13.4x 15.4%
CBUS Cibus, Inc. $108.2M — -14.6%
AVD AMERICAN VANGUARD CORP $30.4M — -5.9%
SNES SenesTech, Inc. $4.6M — 19.6%
BIOX Bioceres Crop Solutions Corp. — — -27.9%
EVGN Evogene Ltd. — — -30.9%